arrow2 Comments
  1. Karl Simpson
    Sep 28 - 5:00 am

    The area of biosimilars is a very interesting one where Europe has led the way. Merck’s efforts in this direction will mean the presence of another large pharma looking to push into biosimilars and will further press home the need for the regulatory and development expertise to bring these products to market.

  2. Ashritha
    Oct 06 - 9:32 am

    My colleagues and I have authored what we believe is India’s first ever complete mapping of the Biosimilars opportunity in India. The report is nowbeing made available to the general public.
    Various issues have been dealt with, such as:
    - Patent expirations
    - Regulatory frameworks
    - Infrastructure Requirements
    - Etc.
    If anyone is interested in this report, please contact me at (infoalcpl AT gmail DOT com), and I would send you the brochure and other details.

Mobile Theme